New research shows the cost of cardiovascular disease (CVD) is set to soar across Europe by 2020.
Figures released by the Centre for Economic and Business Research shows the total cost of CVD in the UK is set to rise by over £3billion in the next six years, from around £15billion in 2014 to over £18billion in 2020.
The study estimates the financial impact of CVD on France, Germany, Spain, Italy, Sweden and UK combined will exceed £97billion by the end of the decade.
From babies with congenital heart defects to grandmothers living with heart failure, they all require medical attention and that comes at a cost
Our Chief Executive, Simon Gillespie, said: “More people than ever are surviving a heart attack and going home to their families thanks to major breakthroughs in the way we treat cardiovascular disease.
“However, the story doesn’t end there as over seven million people across the UK endure a daily battle with long-term heart and circulatory conditions. From babies with congenital heart defects to grandmothers living with heart failure, they all require medical attention throughout their lives and that comes at a cost.
“By funding vital research, the BHF is helping prevent people being struck down with these conditions and live longer, happier lives. We now need Governments across the UK to fully and effectively implement their strategies to tackle cardiovascular disease and ensure everyone receives the care they need.”